Nimmagadda Prasad

Premium

General

30 April, 2024

Grapevine: CX Partners starts Veeda Clinical sale process; Ola CEO departs amid job cuts

CX Partners, a mid-market private equity firm, has started the process to divest its majority stake in Veeda Clinical Research, an ......

Premium

Healthcare

03 January, 2024

Kotak's second special situations PE fund bankrolling big-ticket pharma acquisition

Kotak Alternate Asset Managers (previously Kotak Investment Advisors), the alternative investment arm of Kotak Group, which hit a first close of ......